BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 19877033)

  • 1. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.
    Bilgic H; Ytterberg SR; Amin S; McNallan KT; Wilson JC; Koeuth T; Ellingson S; Newman B; Bauer JW; Peterson EJ; Baechler EC; Reed AM
    Arthritis Rheum; 2009 Nov; 60(11):3436-46. PubMed ID: 19877033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
    Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between lack of angiogenic response in muscle tissue and high expression of angiostatic ELR-negative CXC chemokines in patients with juvenile dermatomyositis: possible link to vasculopathy.
    Fall N; Bove KE; Stringer K; Lovell DJ; Brunner HI; Weiss J; Higgins GC; Bowyer SL; Graham TB; Thornton S; Grom AA
    Arthritis Rheum; 2005 Oct; 52(10):3175-80. PubMed ID: 16200621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course.
    Reed AM; Peterson E; Bilgic H; Ytterberg SR; Amin S; Hein MS; Crowson CS; Ernste F; Gillespie EB
    Arthritis Rheum; 2012 Dec; 64(12):4078-86. PubMed ID: 22886447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum chemokine profile in patients with bullous pemphigoid.
    Nakashima H; Fujimoto M; Asashima N; Watanabe R; Kuwano Y; Yazawa N; Maruyama N; Okochi H; Kumanogoh A; Tamaki K
    Br J Dermatol; 2007 Mar; 156(3):454-9. PubMed ID: 17300233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
    Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
    J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.
    Lee N; Wong CK; Chan PK; Lun SW; Lui G; Wong B; Hui DS; Lam CW; Cockram CS; Choi KW; Yeung AC; Tang JW; Sung JJ
    Clin Infect Dis; 2007 Sep; 45(6):723-31. PubMed ID: 17712756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Skowronski J; Cylwik JP; Cylwik B; Chwiecko J
    J Rheumatol; 2005 Sep; 32(9):1666-72. PubMed ID: 16142858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma.
    Dajotoy T; Andersson P; Bjartell A; Löfdahl CG; Tapper H; Egesten A
    J Leukoc Biol; 2004 Sep; 76(3):685-91. PubMed ID: 15197236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis.
    Greenberg SA; Higgs BW; Morehouse C; Walsh RJ; Kong SW; Brohawn P; Zhu W; Amato A; Salajegheh M; White B; Kiener PA; Jallal B; Yao Y
    Genes Immun; 2012 Apr; 13(3):207-13. PubMed ID: 21881594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoattractant mechanism of Th1 cells in class III and IV lupus nephritis.
    Morimoto S; Tokano Y; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Suzuki J; Kaneko H; Sekigawa I; Takasaki Y
    Autoimmunity; 2009 Feb; 42(2):143-9. PubMed ID: 19021013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elevated plasma concentration of IP-10 in patients with type 2 diabetes mellitus].
    Xu H; Nakayama K; Ogawa S; Sugiura A; Kato T; Sato T; Sato H; Ito S
    Nihon Jinzo Gakkai Shi; 2005; 47(5):524-30. PubMed ID: 16130407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
    Higgs BW; Liu Z; White B; Zhu W; White WI; Morehouse C; Brohawn P; Kiener PA; Richman L; Fiorentino D; Greenberg SA; Jallal B; Yao Y
    Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis.
    Cepok S; Schreiber H; Hoffmann S; Zhou D; Neuhaus O; von Geldern G; Hochgesand S; Nessler S; Rothhammer V; Lang M; Hartung HP; Hemmer B
    Arch Neurol; 2009 Oct; 66(10):1216-23. PubMed ID: 19667211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis.
    Huard C; Gullà SV; Bennett DV; Coyle AJ; Vleugels RA; Greenberg SA
    Br J Dermatol; 2017 May; 176(5):1224-1230. PubMed ID: 27564228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus.
    Hanifi-Moghaddam P; Kappler S; Seissler J; Müller-Scholze S; Martin S; Roep BO; Strassburger K; Kolb H; Schloot NC
    Diabet Med; 2006 Feb; 23(2):156-63. PubMed ID: 16433713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis.
    Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Li PK; Szeto CC
    Nephrol Dial Transplant; 2006 Jun; 21(6):1534-40. PubMed ID: 16449281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes.
    De Benedetti F; Pignatti P; Bernasconi S; Gerloni V; Matsushima K; Caporali R; Montecucco CM; Sozzani S; Fantini F; Martini A
    J Rheumatol; 1999 Feb; 26(2):425-31. PubMed ID: 9972980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis.
    Furuse S; Fujii H; Kaburagi Y; Fujimoto M; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2003 Jul; 30(7):1524-8. PubMed ID: 12858452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.